Effect of von Willebrand factor on inhibitor eradication in patients with severe haemophilia A: A systematic review

British Journal of Haematology

Volumn 166, Issue 4, 2014, Pages 485-495

  van Velzen, Alice S ^a   Peters, Marjolein ^a   van der Bom, Johanna G ^b,c   Fijnvandraat, Karin ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibodies; Haemophilia A; Human factor VIII protein; Immunology; VWF

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; PREDNISOLONE; RITUXIMAB; VON WILLEBRAND FACTOR;

BLEEDING; COHORT ANALYSIS; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; ERADICATION THERAPY; GENETIC HETEROGENEITY; HEMOPHILIA A; HUMAN; IMMUNOLOGICAL TOLERANCE; LOW DRUG DOSE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW;

ANTIBODIES; HAEMOPHILIA A; HUMAN FACTOR VIII PROTEIN; IMMUNOLOGY; VWF;

ANTIBODIES; HEMOPHILIA A; HUMANS; IMMUNE TOLERANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VON WILLEBRAND FACTOR;

EID: 84904965753     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12942     Document Type: Review

References (45)

1. Astermark, J., Morado, M., Rocino, A., van den Berg, H.M., Von, D.M., Gringeri, A., Mantovani, L., Garrido, R.P., Schiavoni, M., Villar, A., Windyga, J. & on behalf of the European Haemophilia Therapy Standardisation Board (2006) Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors. Haemophilia, 12, 363-371.
2. Auerswald, G., Spranger, T. & Brackmann, H.H. (2003) The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patients. [Review] [25 refs]. Haematologica, 88, EREP05.
3. ter Avest, P.C., Fischer, K., Gouw, S.C., van, D.K. & Mauser-Bunschoten, E.P. (2010) Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units. Haemophilia, 16, 71-79.
4. Barnes, C., Rivard, G.E., Poon, M.C., Teitel, J., Pai, M., Kern, M., Blanchette, V.S., Carcao, M. & Inhibitor Subcommittee of Association of Hemophilia Clinic Directors of Canada (2006) Canadian multi-institutional survey of immune tolerance therapy (ITT) - experience with the use of recombinant factor VIII for ITT. Haemophilia, 12, 1-6.
5. Batlle, J., Lopez, M.F., Brackmann, H.H., Gaillard, S., Goudemand, J., Humbert, J., De, M.P., Maass, E., Mauz-Korholz, C., Sultan, Y. & Stieltjes, N. (1999) Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors. Haemophilia, 5, 431-435.
6. Berntorp, E. (2001) Immune tolerance induction: recombinant vs. human-derived product. Haemophilia, 7, 109-113.
7. Berntorp, E., Shapiro, A., Astermark, J., Blanchette, V.S., Collins, P.W., Dimichele, D., Escuriola, C., Hay, C.R.M., Hoots, W.K., Leissinger, C.A., Negrier, C., Oldenburg, J., Peerlinck, K., Reding, M.T. & Hart, C. (2006) Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia, 12, 1-7.
8. Bidlingmaier, C., Kurnik, K., Escuriola-Ettingshausen, C., Jager, R., Klamroth, R., Male, C., Marosi, A., Nemes, L. & von, S.A. & Kreuz, W. (2011) Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH(R)) in 14 patients with severe haemophilia A. Haemophilia, 17, e837-e840.
9. Brackmann, H.H., Oldenburg, J. & Schwaab, R. (1996) Immune tolerance for the treatment of factor VIII inhibitors-twenty years' 'bonn protocol'. Vox Sanguinis, 70(Suppl. 1), 30-35.
10. Callaghan, M.U., Rajpurkar, M., Chitlur, M., Warrier, I. & Lusher, J. (2011) Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans? Haemophilia, 17, 483-489.
11. Coppola, A., Margaglione, M., Santagostino, E., Rocino, A., Grandone, E., Mannucci, P.M. & Di, M.G. (2009) Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors. Journal of Thrombosis and Haemostasis, 7, 1809-1815.
12. Damiano, M.L. & Hutter, J.J. Jr (2000) Immune tolerance for haemophilia patients with inhibitors: analysis of the western United States experience. The Tri-Regional Nursing Group. Haemophilia, 6, 526-532.
13. Dimichele, D. (2009) The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy. Haemophilia, 15, 320-328.
14. Dimichele, D.M., Kroner, B.L. & North American Immune Tolerance Study Group (2002) The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thrombosis & Haemostasis, 87, 52-57.
15. Dimichele, D.M., Blanchette, V. & Berntorp, E. (2012) Clinical trial design in haemophilia. Haemophilia, 18(Suppl. 4), 18-23. doi:10.1111/j.1365-2516.2012.02824.x., 18-23
16. Ehrenforth, S., Kreuz, W., Scharrer, I., Linde, R., Funk, M., Gungor, T., Krackhardt, B. & Kornhuber, B. (1992) Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet, 339, 594-598.
17. Ehrenforth, S., Kreuz, W., Funk, M., Auerswald, G. & Scharrer, I. (1994) Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors [3]. Thrombosis and Haemostasis, 72, 784-785.
18. Ettingshausen, C.E. & Kreuz, W. (2005) Role of von Willebrand factor in immune tolerance induction. Blood Coagulation & Fibrinolysis, 16(Suppl. 1), S27-S31.
19. Fijnvandraat, K., Cnossen, M.H., Leebeek, F.W. & Peters, M. (2012) Diagnosis and management of haemophilia. BMJ, 344, e2707. doi:10.1136/bmj.e2707., e2707
20. Gensana, M., Altisent, C., Aznar, J.A., Casana, P., Hernandez, F., Jorquera, J.I., Magallon, M., Massot, M. & Puig, L. (2001) Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII. Haemophilia, 7, 369-374.
21. Greninger, D.A., Saint-Remy, J.M., Jacquemin, M., Benhida, A. & Dimichele, D.M. (2008) The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile. Haemophilia, 14, 295-302.
22. Gringeri, A., Musso, R., Mazzucconi, M.G., Piseddu, G., Schiavoni, M., Pignoloni, P., Mannucci, P.M. & RITS-FITNHES Study Group (2007) Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response. Haemophilia, 13, 373-379.
23. Hay, C.R. & Dimichele, D.M. (2012) The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood, 119, 1335-1344.
24. Haya, S., Lopez, M.F., Aznar, J.A., Batlle, J. & Spanish Immune Tolerance Group (2001) Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry. Haemophilia, 7, 154-159.
25. Kaveri, S., Mannucci, P.M., Kurth, M.H., Ewing, N., Kessler, C.M., Nugent, D.J. & Gomperts, E.D. (2011) von Willebrand factor: what is its role in the immune response in haemophilia? Haemophilia, 17, e235-e238.
26. Kreuz, W., Ettingshausen, C.E., Auerswald, G., Saguer, I.M., Becker, S., Funk, M., Heller, C., Klarmann, D., Klingebiel, T. & GTH PUP Study Group (2003) Epidemiology of inhibitors and current treatment strategies. [Review] [20 refs]. Haematologica, 88, EREP04.
27. Kurth, M.A., Dimichele, D., Sexauer, C., Sanders, J.M., Torres, M., Zappa, S.C., Ragni, M. & Leonard, N. (2008) Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors. Haemophilia, 14, 50-55. [Errata appear in Haemophilia. 2008 Mar;14(2):414] and Jul;14(4):878].
28. Kurth, M., Puetz, J., Kouides, P., Sanders, J., Sexauer, C., Bernstein, J., Gruppo, R., Manco-Johnson, M., Neufeld, E.J., Rodriguez, N., Wicklund, B., Quon, D. & Aledort, L. (2011) The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience. Journal of Thrombosis and Haemostasis, 9, 2229-2234.
29. Lenk, H. (2000) The German Registry of immune tolerance treatment in hemophilia-1999 update. Haematologica, 85, 45-47.
30. Lin, P.C., Liao, Y.M., Tsai, S.P. & Chang, T.T. (2011) Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens. Pediatric Blood & Cancer, 57, 1029-1033.
31. Mariani, G. & Kroner, B. (2001) Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success. Haematologica, 86, 1186-1193.
32. Mariani, G., Scheibel, E., Nogao, T., Kasper, C.K., Ewing, N.P., Mauser-Bunschoten, E., Ghirardini, A., Bellocco, R. & Brackman, H.H. (1994) Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols. Seminars in Hematology, 31(Suppl. 4), 62-64.
33. Mauser-Bunschoten, E.P., Posthouwer, D., Fischer, K. & van den Berg, H.M. (2007) Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up. Haemophilia, 13, 697-700.
34. Moher, D., Liberati, A., Tetzlaff, J. & Altman, D.G. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, b2535. doi:10.1136/bmj.b2535., b2535
35. Orsini, F., Rotschild, C., Beurrier, P., Faradji, A., Goudemand, J. & Polack, B. (2005) Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors. Haematologica, 90, 1288-1290.
36. Rivard, G.E., Rothschild, C., Toll, T. & Achilles, K. (2013) Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study. Haemophilia, 19, 449-455.
37. Rocino, A., Santagostino, E., Mancuso, M.E. & Mannucci, P.M. (2006) Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors. Haematologica, 91, 558-561.
38. Salviato, R., Belvini, D., Radossi, P., Sartori, R., Pierobon, F., Zanotto, D., Zanon, E., Castaman, G., Gandini, G. & Tagariello, G. (2007) F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors. Haemophilia, 13, 361-372.
39. Smith, M.P., Spence, K.J., Waters, E.L., Beresford-Webb, R., Mitchell, M.J., Cuttler, J., Alhaq, A., Brown, S.A. & Savidge, G.F. (1999) Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution. Thrombosis & Haemostasis, 81, 35-38.
40. Suzuki, T., Arai, M., Amano, K., Kagawa, K. & Fukutake, K. (1996) Factor VIII inhibitor antibodies with C2 domain specificity are less inhibitory to factor VIII complexed with von Willebrand factor. Thrombosis and Haemostasis, 76, 749-754.
41. Unuvar, A., Warrier, I. & Lusher, J.M. (2000) Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors. Haemophilia, 6, 150-157.
42. Unuvar, A., Kavakli, K., Baytan, B., Kazanci, E., Sayli, T., Oren, H., Celkan, T. & Gursel, T. (2008) Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors. Haemophilia, 14, 315-322.
43. Valentino, L.A., Recht, M., DiPaola, J., Shapiro, A.D., Pipe, S.W., Ewing, N., Urgo, J., Bullock, T., Simmons, M. & Deguzman, C. (2009) Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia A. Haemophilia, 15, 718-726.
44. Van Leeuwen, E.F., Mauser-Bunschoten, E.P., Van Dijken, P.J., Kok, A.J., Sjamsoedin-Visser, E.J. & Sixma, J.J. (1986) Disappearance of factor VIII: C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose. British Journal of Haematology, 64, 291-297.
45. Wight, J., Paisley, S. & Knight, C. (2003) Immune tolerance induction in patients with haemophilia A with inhibitors: a systematic review. [Review] [54 refs]. Haemophilia, 9, 436-463.